What is the best approach for a 78-year-old male with Staphylococcus haemolyticus bacteremia on vancomycin (Vancomycin) and right toe cellulitis with possible fungal involvement on Ambisome (Amphotericin B)/Voriconazole (Voriconazole), considering the role of imaging and beta-D-glucan as a biomarker?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Staphylococcus haemolyticus Bacteremia with Toe Cellulitis and Possible Fungal Co-infection

For a 78-year-old male with Staphylococcus haemolyticus bacteremia on vancomycin and right toe cellulitis with possible fungal involvement currently on amphotericin B (Ambisome) and voriconazole, advanced imaging is essential for evaluating disease progression, and beta-D-glucan testing should be used to confirm fungal infection while continuing current antimicrobial therapy.

Role of Imaging in Worsening Infection

  • MRI is the preferred imaging modality for detecting bone involvement, deep soft-tissue abscesses, or sinus tracts in patients with worsening toe cellulitis, providing the most accurate assessment of infection extent 1
  • Plain radiographs should be obtained initially to evaluate for osteomyelitis, with follow-up imaging in 2-4 weeks if initial films are negative but clinical suspicion remains high 1
  • High-resolution ultrasonography or CT scanning may be helpful specifically for detecting deep soft-tissue abscesses or sinus tracts that might require drainage 1
  • Nuclear medicine scans (especially those with labeled leukocytes) are highly sensitive and may be useful in some cases but are generally less specific than MRI 1
  • For patients with worsening infection despite appropriate therapy, imaging should be performed to assess for complications such as abscess formation requiring surgical intervention 1

Role of Beta-D-Glucan Testing

  • Blood cultures should be obtained and skin lesions should be aggressively evaluated by culture aspiration, biopsy, or surgical excision, as they may be caused by resistant microbes, yeast, or molds 1
  • Beta-D-glucan testing can help confirm fungal involvement, though sensitivity of a single-serum fungal antigen test is low, particularly in patients already receiving antifungal agents 1
  • Tissue samples should be obtained whenever possible for culture, as they generally provide more accurate results than superficial swab specimens 1
  • For definitive diagnosis of fungal infection, biopsy or aspiration of the lesion(s) to obtain material for histological, cytological, and microbiological evaluation is recommended 1

Treatment Approach

For Staphylococcus haemolyticus Bacteremia

  • Continue vancomycin for Staphylococcus haemolyticus bacteremia, ensuring appropriate dosing to maintain trough concentrations of 15-20 μg/mL in severe infections 1
  • Consider adding a beta-lactam agent (such as piperacillin-tazobactam) to the vancomycin regimen for severe non-purulent skin and soft tissue infections with systemic signs of infection 1
  • For persistent bacteremia, evaluate for metastatic foci of infection using appropriate imaging modalities 2
  • Duration of antimicrobial therapy should be at least 2 weeks after clearance of bloodstream infection 1

For Possible Fungal Co-infection

  • Continue current antifungal therapy with amphotericin B (Ambisome) and voriconazole while awaiting definitive diagnosis 1
  • If Aspergillus is confirmed, voriconazole is the preferred treatment (strong recommendation), with a 53% response rate as primary therapy compared to 32% with amphotericin B alone 3
  • For Candida infections, an echinocandin should be used, or if Candida parapsilosis is isolated, lipid formulation amphotericin B is recommended 1
  • For Mucor/Rhizopus infections, lipid formulation amphotericin B or posaconazole is recommended 1
  • Treatment duration for fungal infections should be 6-12 weeks for Aspergillus and 2 weeks after clearance of bloodstream infection for Candida 1, 3

Surgical Considerations

  • Debridement is crucial for removing necrotic tissue and slough, reducing pressure at callused sites, removing colonizing bacteria, and facilitating collection of appropriate specimens for culture 1
  • Use a sterile, blunt metal probe to measure the depth and extent of the wound, noting any foreign bodies, soft-tissue abscesses, communications with joint cavities or tendon sheaths, or palpable bone 1
  • Surgical intervention is recommended for drainage of soft tissue abscess, especially for progressive polymicrobial infection 1
  • Complex abscesses typically respond to incision and drainage with adjuvant antibiotic therapy 1

Monitoring and Follow-up

  • Monitor for clearance of bacteremia with serial blood cultures 2
  • Following debridement, measure and record the wound size, extent of surrounding cellulitis, and quality and quantity of drainage to assess healing progress 1
  • Evaluate for persistent fever, which may indicate inadequate source control, resistant organisms, or fungal co-infection 1
  • Consider repeat imaging if clinical improvement is not observed within 5-7 days of appropriate antimicrobial therapy 1

Special Considerations for Elderly Patients

  • Elderly patients may have atypical presentations of infection with less pronounced inflammatory signs 1
  • Assess for underlying conditions that may complicate treatment, such as peripheral vascular disease or neuropathy 1
  • Carefully monitor renal function with vancomycin therapy, as elderly patients are at higher risk for nephrotoxicity 1
  • Consider potential drug interactions between antifungal agents and other medications the patient may be taking 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.